Latest filings (excl ownership)
8-K
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
6 Mar 24
10-Q
2024 Q1
Quarterly report
20 Feb 24
10-K/A
2023 FY
Annual report (amended)
15 Feb 24
NT 10-Q
Notice of late quarterly filing
15 Feb 24
10-K
2023 FY
Annual report
5 Jan 24
NT 10-K
Notice of late annual filing
29 Dec 23
8-K
Other Events
27 Nov 23
10-Q
2023 Q3
Quarterly report
21 Aug 23
NT 10-Q
Notice of late quarterly filing
15 Aug 23
8-K
Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer
29 Jun 23
425
Business combination disclosure
26 May 23
8-K
Theralink® Signs Definitive Merger Agreement to be Acquired by
26 May 23
10-Q
2023 Q2
Quarterly report
15 May 23
8-K
Departure of Directors or Certain Officers
11 May 23
10-Q
2022 Q1
Quarterly report
21 Feb 23
NT 10-Q
Notice of late quarterly filing
15 Feb 23
8-K
Entry into a Material Definitive Agreement
1 Feb 23
10-K
2022 FY
Annual report
29 Dec 22
D
$3.40 mm in debt / options, 12 investors
14 Dec 22
8-K
Theralink® Technologies Appoints Seasoned Commercial Leader, Faith Zaslavsky, as President & Chief
8 Dec 22
8-K
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
1 Dec 22
8-K
Entry into a Material Definitive Agreement
16 Sep 22
10-Q
2022 Q3
Quarterly report
15 Aug 22
8-K/A
Amendments to Articles of Incorporation or Bylaws
11 Jul 22
8-K
Amendments to Articles of Incorporation or Bylaws
7 Jul 22
DEF 14C
Information statement
2 Jun 22
10-Q
2022 Q2
Quarterly report
23 May 22
PRE 14C
Preliminary information
20 May 22
NT 10-Q
Notice of late quarterly filing
17 May 22
8-K
Departure of Directors or Certain Officers
5 Apr 22
10-Q
2022 Q1
Quarterly report
18 Feb 22
NT 10-Q
Notice of late quarterly filing
15 Feb 22
8-K
Entry into a Material Definitive Agreement
3 Feb 22
10-K
2021 FY
Annual report
13 Jan 22
8-K
Departure of Directors or Certain Officers
5 Jan 22
NT 10-K
Notice of late annual filing
30 Dec 21
8-K
Entry into a Material Definitive Agreement
29 Nov 21
8-K
Entry into a Material Definitive Agreement
5 Nov 21
10-Q
2021 Q3
Quarterly report
28 Sep 21
10-Q
2021 Q2
Quarterly report
27 Sep 21
Latest ownership filings
4
Jeffrey Busch
2 Feb 24
4
Danica Holley
26 Jan 24
4
Matthew Wilson Schwartz
26 Jan 24
3
Faith Zaslavsky
19 Dec 23
4
Matthew Wilson Schwartz
26 Sep 22
4
YVONNE FORS
22 Sep 22
4
Jeffrey Busch
21 Sep 22
4
III Thomas E. Chilcott,
21 Sep 22
4
MICHAEL I RUXIN
21 Sep 22
4
Danica Holley
22 Jun 22
3
Matthew Wilson Schwartz
21 Jun 22
3
Danica Holley
5 Apr 22
3
III Thomas E. Chilcott,
6 Oct 20
3
YVONNE FORS
24 Jun 20
3
Jeffrey Busch
18 Jun 20
3
MICHAEL I RUXIN
18 Jun 20
SC 13D
Avant Diagnostics, Inc
15 Jun 20
3
Initial statement of insider ownership
15 Jun 20
4
ANDREW ALBERT KUCHARCHUK
9 Jun 20
4
ANDREW ALBERT KUCHARCHUK
8 May 20
4
JONATHAN FREDERICK HEAD
8 May 20
4
ROBERT NEAL HOLCOMB
30 Apr 19
4
CHARLES L RICE JR
30 Apr 19
4
Daniel S. Hoverman
30 Apr 19
4
Brian Gill Barnett
30 Apr 19
4/A
Daniel S. Hoverman
14 Mar 19
4/A
CHARLES L RICE JR
14 Mar 19
3/A
Brian Gill Barnett
14 Mar 19
4/A
ANDREW ALBERT KUCHARCHUK
14 Mar 19
4/A
JONATHAN FREDERICK HEAD
14 Mar 19
3/A
ROBERT NEAL HOLCOMB
14 Mar 19
4/A
JONATHAN FREDERICK HEAD
14 Mar 19
3
Brian Gill Barnett
7 Jan 19
3
ROBERT NEAL HOLCOMB
22 May 18
4
ANDREW ALBERT KUCHARCHUK
11 May 18
4
JONATHAN FREDERICK HEAD
11 May 18
4
Daniel S. Hoverman
11 May 18
4
CHARLES L RICE JR
11 May 18
4
CHARLES L RICE JR
20 Apr 17
4
ANDREW ALBERT KUCHARCHUK
20 Apr 17